These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4297909)

  • 1. Studies on the protection test of pertussis vaccine. Immunization period and protectivity. 3. Influence of heat and formation on the vaccine preparation.
    Yoshioka M; Takatsu K; Kawahira M; Takahashi K
    Jpn J Microbiol; 1967 Dec; 11(4):311-21. PubMed ID: 4297909
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigens of Bordetella pertussis. IV. Effect of heat, merthiolate, and formaldehyde on histamine-sensitizing factor and protective activity of soluble extracts from Bordetella pertussi.s.
    Munoz J; Hestekin BM
    J Bacteriol; 1966 Jun; 91(6):2175-9. PubMed ID: 4287581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutaraldehyde inactivated pertussis vaccine: a less histamine sensitizing vaccine.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1987 Apr; 15(2):159-64. PubMed ID: 3110164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced adjuvant activity of Bordetella pertussis on the secondary immune response of mice evoked by an immunogenic threshold dose of sheep erythrocytes.
    Finger H; Emmerling P; Köthe G
    Pathol Microbiol (Basel); 1969; 34(6):340-51. PubMed ID: 4319348
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of the route of immunization on the protection of mice infected intracerebrally with Bordetella pertussis.
    Standfast AF; Dolby JM
    J Hyg (Lond); 1972 Sep; 70(3):487-501. PubMed ID: 4341998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time relationships between injection of antigen and adjuvant. II. Immunosuppression induced by Bordetella pertussis vaccine when given before secondary antigenic stimulation.
    Finger H; Bartoschek M; Emmerling P
    Pathol Microbiol (Basel); 1972; 38(2):93-102. PubMed ID: 4337644
    [No Abstract]   [Full Text] [Related]  

  • 7. Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response.
    Lavigne MV; Castro M; Andino J; Manghi M
    Microbes Infect; 2004 Apr; 6(5):481-4. PubMed ID: 15109963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of orally administered Bordetella pertussis vaccine in mice.
    Hof H; Finger H; Körner L; Milcke L
    Dev Biol Stand; 1976; 33():47-53. PubMed ID: 182602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [General immunogenesis after oral uptake of killed Pertussis bacteria].
    Hof H; Finger H
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):282-8. PubMed ID: 4154597
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of Bordetella pertussis preserved in liquid nitrogen as a challenge suspension in the Kendrick mouse protection test.
    Novotny P; Brookes JE
    J Biol Stand; 1975; 3(1):11-29. PubMed ID: 165201
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigen-sensitive spleen cells and the adjuvant activity of Bordetella pertussis.
    Finger H; Emmerling P; Büsse M
    Can J Microbiol; 1970 Jul; 16(7):623-7. PubMed ID: 4319471
    [No Abstract]   [Full Text] [Related]  

  • 12. Action of vaccinia virus on the reactivity of albino mice inoculated with pertussis vaccine.
    Pozsgi N; David C; Andreescu V; Caffé I; Ghyka G
    Z Immunitatsforsch Exp Klin Immunol; 1971 Aug; 142(2):129-35. PubMed ID: 4105636
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimization of immunization schedule to standardize antibody response in mice to pertussis vaccines.
    Tiru M; Jäätmaa E; Gillenius P; Askelöf P
    Dev Biol Stand; 1985; 61():469-75. PubMed ID: 2872128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant principle of pertussis vaccine in the mouse.
    Pieroni RE; Levine L
    Nature; 1966 Sep; 211(5056):1419-20. PubMed ID: 4291099
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the protection test of pertussis vaccine. Immunization period and protectivity. II. Variations among mouse strains.
    Yoshioka M; Takatsu K; Kawahira M
    Jpn J Microbiol; 1965 Mar; 9(1):21-33. PubMed ID: 5294323
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles.
    Cahill ES; O'Hagan DT; Illum L; Barnard A; Mills KH; Redhead K
    Vaccine; 1995 Apr; 13(5):455-62. PubMed ID: 7639014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal and systemic immunogenicity of a recombinant, non-ADP-ribosylating pertussis toxin: effects of formaldehyde treatment.
    Cropley I; Douce G; Roberts M; Chatfield S; Pizza M; Marsili I; Rappuoli R; Dougan G
    Vaccine; 1995 Dec; 13(17):1643-8. PubMed ID: 8719514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis.
    Alvarez Hayes J; Oviedo JM; Valdez H; Laborde JM; Maschi F; Ayala M; Shah R; Fernandez Lahore M; Rodriguez ME
    Microbiol Immunol; 2017 Oct; 61(10):407-415. PubMed ID: 28857261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxonomic distribution of the antigen eliciting bactericidal antibody for Bordetella pertussis.
    Dolby JM; Ackers JP
    J Gen Microbiol; 1975 Apr; 87(2):239-44. PubMed ID: 49392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved efficacy of a licensed acellular pertussis vaccine, reformulated in an adjuvant emulsion of liposomes in oil, in a murine model.
    Mansour M; Brown RG; Morris A; Smith B; Halperin SA
    Clin Vaccine Immunol; 2007 Oct; 14(10):1381-3. PubMed ID: 17715327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.